Company intelligence / Profile preview

Rochester Clinical Research

Rochester, New York, United States

Ownership: Private
Employees: ~42
Development stage: Other

Overview

Rochester Clinical Research has conducted over 1,200 clinical trials since 1994, serving more than 55,000 volunteers, with ongoing trials in cardiovascular disease, smoking cessation, migraine, and genital herpes among others

Therapeutic areas: Infectious DiseasesCardiovascularNeurologyPsychiatry
Modalities: Small moleculeBiologicVaccineDevicePeptidesProteinMonoclonal antibody
Industry: Contract Research Organization

Partnerships

Atlas Clinical ResearchPfizerMerck

Beyond the preview

Go deeper on Rochester Clinical Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rochester Clinical Research.

Explore the full profile